$70 Million in Damages Awarded in Risperdal Gynecomastia Suit

In one of the latest verdicts in the Risperdal litigation, on July 1, 2016 a Pennsylvania jury ordered manufacturer Johnson & Johnson to pay $70 million in damages to a teenager. The teen claims that after taking the antipsychotic drug as a boy, he later developed female-like breasts—a side-effect called gynecomastia that the drugmaker allegedly knew about but hid from the FDA. Several similar cases have been filed against Johnson & Johnson, with some cases resulting in multi-million dollar verdicts, yet this recent decision is the largest thus far in the litigation.

If you or your son developed breasts while taking Risperdal, please contact us at 888-931-4335 for a confidential evaluation of your potential claim.

Real Time Analytics